Philip Shackley

Dr Philip Shackley is a researcher affiliated with Newcastle University, focusing on health economics, cost-effectiveness analysis, and public health. His work spans clinical trials, health policy, and economic valuation methods, with a strong emphasis on neurological rehabilitation and global healthcare challenges.

• Specializes in health economics and cost-effectiveness of medical interventions.
• Collaborated on landmark trials like BoTULS (stroke spasticity) and SANAD (epilepsy).
• Key methodologies: contingent valuation, discrete choice experiments, and QALY valuation.

Research Interests

Shackley’s research centers on quantifying the economic and clinical impacts of healthcare interventions. His studies address:

• Cost-effectiveness of botulinum toxin for post-stroke spasticity.
• Comparative analysis of dental and epilepsy treatments.
• Public valuation of health programs via willingness-to-pay frameworks.
• Global health disparities (e.g., stroke treatment in Tanzania).

Publications highlight methodological rigor in clinical trials and economic modeling. Awards and student supervision details are not publicly listed here.